Givaudan SA AI Stock Analysis
Givaudan SA (GIN1) AI Stock Analysis
Givaudan SA
(Frankfurt:GIN1)
No summary available
Givaudan SA (GIN1) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 44.74B
- Dividend Yield
- 1.87%
- Average Volume (3M)
- 107
- Price to Earnings (P/E)
- 30.2
- Beta (1Y)
- 0.56
- Revenue Growth
- 0.13%
- EPS Growth
- -11.21%
- Country
- Germany
- Employees
- 17,580
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals - Specialty
Givaudan SA Business Overview & Revenue Model
Company Description
Founded in Vernier, Switzerland in 1796, Givaudan SA is a global leader specializing in the development, production, and supply of fragrance, beauty, taste, and wellbeing solutions for the consumer goods industry. The company operates through two cor...
Givaudan SA Earnings Call Summary
The call conveyed a balanced message: solid operational momentum (notably in Fragrance & Beauty and Asia), clear signs of sequential recovery in Taste & Wellbeing, continued investment in innovation and sustainability, and re-affirmation of medium-term 2030 targets. Offsetting these positives were material nonrecurring litigation and provision charges (CHF 103m), weaker reported net income and EPS, negative adjusted free cash flow in H1, higher net debt/leverage and elevated working capital. Management expressed confidence in normalization of working capital, improved cash generation in H2 and delivery against the 2030 strategic ambitions, but the near-term financial impacts of one-offs and regional softness leave the picture mixed.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Guidance from the call reaffirmed the 2030 targets of 4–6% like‑for‑like sales growth and an average adjusted free cash flow margin above 12% over the 2026–2030 cycle; management expects stronger cash generation in H2 after adjusted free cash flow of minus CHF119m (‑3.1% of sales) in H1, and reiterated net investment guidance of 4–5% of sales (net investments were 5.4% in H1). They signalled low single‑digit input cost inflation in H2 (with a $10 oil move ≈ 1% effect on synthetics), that partial U.S. tariff refunds will be passed back to customers in H2 (broadly offsetting inflation‑related pricing), and a continued sequential recovery in Taste & Wellbeing alongside strong momentum in Fragrance & Beauty. Financial pacing to note: H1 adjusted EBITDA CHF923m (margin 24.3% vs 25.2% prior), adjusted EPS H1 CHF60.25, net debt CHF4.6bn (net debt/EBITDA 2.8x) and net working capital 30.8% of sales (expect meaningful improvement by year‑end); management expects full‑year EBITDA to be around the mid‑24% range on current visibility.
Givaudan SA Peers Comparison
Overall Rating
BCPC79Outperform
ECL72Outperform
IFF62Neutral
SXT62Neutral
SCL55Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 79Outperform | $5.39B | 31.71 | 13.21% | 0.57% | 9.42% | 16.31% | |
| 72Outperform | $84.87B | 41.09 | 20.70% | 0.96% | 9.33% | 5.71% | |
| 62Neutral | $19.89B | 105.38 | 1.41% | 2.01% | -16.67% | ― | |
| 62Neutral | $4.97B | 29.26 | 13.66% | 1.40% | 9.54% | 21.44% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 55Neutral | $1.50B | 349.05 | 0.36% | 2.40% | 10.02% | -90.50% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:GIN1 | Givaudan SA | 87.50 | 18.18 | 26.23% | |
| BCPC | Balchem | 168.73 | 16.94 | 11.16% | |
| ECL | Ecolab | 300.68 | 41.76 | 16.13% | |
| IFF | International Flavors & Fragrances | 80.08 | 16.93 | 26.80% | |
| SXT | Sensient | 117.54 | 25.59 | 27.83% | |
| SCL | Stepan Company | 66.05 | 24.68 | 59.64% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
